Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Testicular Neoplasms 22Kidney Neoplasms 18Ovarian Neoplasms 17Testicular Germ Cell Tumor 16Urinary Bladder Neoplasms 14Wilms Tumor 13Sarcoma 13Teratoma 10Central Nervous System Neoplasms 10Neuroectodermal Tumors, Primitive, Peripheral 9Neuroblastoma 9Carcinoma, Renal Cell 9Prostatic Neoplasms 8Endodermal Sinus Tumor 8Seminoma 7Medulloblastoma 7Carcinoma, Embryonal 7Retinoblastoma 6Osteosarcoma 6Astrocytoma 6Ovarian Germ Cell Cancer 5Optic Nerve Glioma 5Neoplasm Metastasis 5Melanoma 5Lymphoma 5Recurrence 4Liver Neoplasms 4Head and Neck Neoplasms 4Familial ependymoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Analgesia 6Zoledronic Acid 5Prednisone 4Docetaxel 4Radiotherapy 3cabozantinib 2Psychiatric Rehabilitation 2Mitoxantrone 2Lidocaine 2Filgrastim 2Cystoscopy 2tandutinib 1strontium chloride 1pegfilgrastim 1Vitamin D 1Vertebroplasty 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Strontium-89 1Samarium-153 1Radium-223 1Radiation 1Oxygen 1Observation 1Nitrous Oxide 1Morphine 1Midazolam 1Methadone 1Mepivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain × Filgrastim × Genitourinary × Clear all
NCT00503984 2016-06-09

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

University of Miami

Phase 1/2 Terminated
22 enrolled 16 charts
Genitourinary

Pain, Prostatic Neoplasms

NCT00005960 2013-12-04

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡